Your browser doesn't support javascript.
loading
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
Stelljes, Matthias; Raffel, Simon; Alakel, Nael; Wäsch, Ralph; Kondakci, Mustafa; Scholl, Sebastian; Rank, Andreas; Hänel, Mathias; Spriewald, Bernd; Hanoun, Maher; Martin, Sonja; Schwab, Katjana; Serve, Hubert; Reiser, Lena; Knaden, Julian; Pfeifer, Heike; Marx, Julia; Sauer, Tim; Berdel, Wolfgang E; Lenz, Georg; Brüggemann, Monika; Gökbuget, Nicola; Wethmar, Klaus.
Affiliation
  • Stelljes M; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
  • Raffel S; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Alakel N; Medizinische Klinik und Poliklinik I, Universitätsklinikum, Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Wäsch R; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kondakci M; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Scholl S; Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.
  • Rank A; Department of Hematology and Oncology, University Medical Center Augsburg, Augsburg, Germany.
  • Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Spriewald B; Department of Internal Medicine V, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Hanoun M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
  • Martin S; Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Schwab K; Department of Medicine III, Hematology, Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
  • Serve H; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Reiser L; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Knaden J; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Pfeifer H; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Marx J; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
  • Sauer T; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Berdel WE; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
  • Lenz G; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
  • Brüggemann M; Department of Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Gökbuget N; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Wethmar K; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany.
J Clin Oncol ; 42(3): 273-282, 2024 Jan 20.
Article in En | MEDLINE | ID: mdl-37883727
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2024 Document type: Article Affiliation country: